Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2- early breast cancer
NATALEE 研究的原理和试验设计:一项针对 HR+/HER2- 早期乳腺癌患者的辅助治疗方案(利博西尼联合内分泌治疗与单纯内分泌治疗)的 III 期临床试验
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231178125
Slamon, Dennis J; Fasching, Peter A; Hurvitz, Sara; Chia, Stephen; Crown, John; Martín, Miguel; Barrios, Carlos H; Bardia, Aditya; Im, Seock-Ah; Yardley, Denise A; Untch, Michael; Huang, Chiun-Sheng; Stroyakovskiy, Daniil; Xu, Binghe; Moroose, Rebecca L; Loi, Sherene; Visco, Frances; Bee-Munteanu, Valerie; Afenjar, Karen; Fresco, Rodrigo; Taran, Tetiana; Chakravartty, Arunava; Zarate, Juan Pablo; Lteif, Agnes; Hortobagyi, Gabriel N